Cardiovascular disease biomarkers across autoimmune diseases
| Autor: | Joseph M. Ahearn, Chau-Ching Liu, Kelly J. Shields, Susan Manzi |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Immunology
Autoimmunity Inflammation Coronary Artery Disease Disease medicine.disease_cause Bioinformatics Carotid Intima-Media Thickness Autoimmune Diseases Lipid oxidation medicine Humans Immunology and Allergy Disease biomarker Autoimmune disease Systemic lupus erythematosus business.industry Calcinosis medicine.disease Intima-media thickness Cardiovascular Diseases Calcium medicine.symptom Lipoproteins HDL business Biomarkers |
| Zdroj: | Clinical Immunology. 161:59-63 |
| ISSN: | 1521-6616 |
| Popis: | Cardiovascular disease is increasingly recognized as a major cause of premature mortality among those with autoimmune disorders. There is an urgent need to identify those patients with autoimmune disease who are at risk for CVD so as to optimize therapeutic intervention and ultimately prevention. Accurate identification, monitoring and stratification of such patients will depend upon a panel of biomarkers of cardiovascular disease. This review will discuss some of the most recent biomarkers of cardiovascular diseases in autoimmune disease, including lipid oxidation, imaging biomarkers to characterize coronary calcium, plaque, and intima media thickness, biomarkers of inflammation and activated complement, genetic markers, endothelial biomarkers, and antiphospholipid antibodies. Clinical implementation of these biomarkers will not only enhance patient care but also likely accelerate the pharmaceutical pipeline for targeted intervention to reduce or eliminate cardiovascular disease in the setting of autoimmunity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect